Skip to main content
Peter Martin, MD, Hematology, New York, NY

Peter Martin MD

Hematology•New York, NY

Hematologic Oncology

Professor of Medicine Perlmutter Cancer Center NYU Langone

Join to view full profile

  • 240 E 38th St.19th FloorNew York, NY 10016

  • Phone+1 929-573-1365

Dr. Martin is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Martin's full profileAlready have an account?

Summary

  • Dr. Peter Martin is a hematology specialist located in New York, NY, with subspecialties in hematologic oncology. He completed his residency in internal medicine and fellowship in hematology at McGill University. Dr. Martin currently serves as a professor and attending physician at NYU Langone and New York-Presbyterian Hospital. His extensive experience includes conditions like non-Hodgkin and Hodgkin lymphoma. He has contributed to multiple reputable publications and is involved in various clinical trials.

Education & Training

  • McGill University
    McGill UniversityFellowship in Hematology, 2004 - 2006
  • University of Alberta
    University of AlbertaClass of 2001
  • Cornell University
    Cornell UniversityMS

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2022 - Present
  • NY State Medical License
    NY State Medical License 2009 - 2028
  • Hematology
    American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012-2014, 2016-2017
  • CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012-2014, 2016-2017
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • T-Cell Clonal Expansion and Activation Associated with Durable Clinical Response to Dual BTK and CDK4/6 Inhibitor Therapy in Mantle Cell Lymphoma
    Peter Martin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Vulnerable Elders Survey-13 (VES-13) Predicts 1-Year Mortality Risk in Newly Diagnosed Non-Hodgkin Lymphoma (NHL)
    Peter Martin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Clinical Trial Participation Is Associated with Improved Overall Survival in Newly Diagnosed Patients with Mantle Cell Lymphoma
    Peter Martin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Press Mentions

  • Who Qualifies for a Coronavirus Booster Shot? Why It’s Still Unclear
    Who Qualifies for a Coronavirus Booster Shot? Why It’s Still UnclearAugust 13th, 2021
  • The Complex Situation for Immunocompromised People and COVID-19 Vaccines
    The Complex Situation for Immunocompromised People and COVID-19 VaccinesJune 16th, 2021
  • Assessing Response to Follicular Lymphoma Treatment
    Assessing Response to Follicular Lymphoma TreatmentSeptember 24th, 2020

Professional Memberships

Other Languages

  • Spanish, French

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Peter Martin, Dr. Peter Martin, MD, Dr. P Martin